Corbus Pharmaceuticals Holdings, Inc. (CRBP) 6.37
Post# of 658
6.37+0.12 (+1.92%) took few more cents in a/h 6.45 +1.26 but only on 4k volume
Day's Range 6.20 - 6.70
CRBP will remain on m daily list for any scalps that might appear
Corbus has surged 325% in 2016 due to Resunab, which received an FDA 'Fast Track' designation. Corbus CEO Dr. Yuval Cohen does not expect things to slow down anytime soon.
[url= https://www.thestreet.com/story/13750525/1/co...yptr=yahoo[/url]
Don't be afraid to be outnumbered. Pigeons flock together. Eagle fly alone